10x Genomics (TXG) Receivables - Other (2024 - 2026)

10x Genomics' Receivables - Other history runs 3 years deep, the most recent figure standing at $17.1 million for Q1 2026.

• In Q1 2026, Receivables - Other changed N/A year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $17.1 million (changed N/A YoY), while the FY2025 annual figure was $35.5 million, up 5754.79% from the prior year.
• Receivables - Other came in at $17.1 million for Q1 2026 at 10x Genomics, down from $35.5 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $69.1 million in Q2 2025 to a low of $606000.0 in Q4 2024.
• A 3-year average of $35.0 million and a median of $35.5 million in 2025 frame the typical range for Receivables - Other.
• On a YoY basis, Receivables - Other climbed as much as 5754.79% in 2025 and fell as far as 5754.79% in 2025.
• 10x Genomics' Receivables - Other stood at $606000.0 in 2024, then jumped by 5754.79% to $35.5 million in 2025, then slumped by 51.79% to $17.1 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $17.1 million, $35.5 million, and $52.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison